Peptide Therapy, Compounding & Pharmacy Practice
The fastest-evolving corner of compounding pharmacy, taught with the clinical medicine behind it. Understand not only how a preparation is compounded — but why it is being prescribed, for whom, and under which regulatory framework.
Pharmacists learn the medicine, not just the preparation
Pharmacists participate in the full multidisciplinary curriculum alongside physicians, NPs and PAs — peptide science, patient conditions, therapeutic objectives, clinical decision-making, safety and monitoring — and then go deeper where pharmacy practice demands it.
The prescriber asks
Is this therapy clinically appropriate for this patient — and how is it selected, dosed and monitored?
The pharmacist asks
Can and should this preparation be compounded and dispensed? Which regulatory framework applies, which quality considerations matter, and what must pharmacist and prescriber communicate?
Empire brings both perspectives together in one program.
Built for today’s peptide environment
A dedicated portion of the curriculum examines pharmaceutical compounding and the regulatory environment surrounding peptide therapies. Topics include:
- 503A compounding pharmacies and 503B outsourcing facilities
- FDA regulation of compounded drugs and bulk drug substances — including changing FDA positions on compounded peptides
- API sourcing, supplier qualification and Certificates of Analysis
- Quality, purity, sterility, stability, storage and handling
- USP sterile and nonsterile compounding principles, where applicable
- Patient-specific prescription considerations, documentation and compliance
- Concentration, formulation, dosing and medication-safety considerations
- Pharmacist–prescriber communication, with case studies of commonly compounded peptides
Taught with a healthcare law firm
Peptide compounding lives inside a complex, fast-moving regulatory environment. The curriculum’s dedicated legal education — presented in collaboration with an experienced healthcare law firm — addresses compounded medications, documentation, sourcing, prescribing and the compliance issues that reach both clinical and pharmacy practice.
Accredited education, in one certification pathway
The program provides physicians with up to 40 AMA PRA Category 1 Credits™. Continuing-education designation for pharmacists is being finalized with our accreditor and will be published before enrollment opens — so you can decide with full information.
Whether you are a community, clinical, consultant or compounding pharmacist — or a pharmacy owner — the certification provides a comprehensive pathway into the field intersecting compounding pharmacy, functional medicine and peptide therapy.
Understand the peptide. Understand the patient. Understand the prescription. Understand the regulations.